BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1251 related articles for article (PubMed ID: 25072528)

  • 1. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Murray V; Berge E; del Zoppo GJ
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD000213. PubMed ID: 25072528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Murray V; Berge E; Del Zoppo GJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000213. PubMed ID: 19821269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Wardlaw JM; Koumellis P; Liu M
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous vascular interventions for acute ischaemic stroke.
    O'Rourke K; Berge E; Walsh CD; Kelly PJ
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007574. PubMed ID: 20927761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke.
    Roaldsen MB; Jusufovic M; Berge E; Lindekleiv H
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD007574. PubMed ID: 34125952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen depleting agents for acute ischaemic stroke.
    Hao Z; Liu M; Counsell C; Wardlaw JM; Lin S; Zhao X
    Cochrane Database Syst Rev; 2012 Mar; (3):CD000091. PubMed ID: 22419274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolytic treatment and endovascular thrombectomy for ischaemic wake-up stroke.
    Roaldsen MB; Lindekleiv H; Mathiesen EB
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010995. PubMed ID: 34850380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke.
    Lindekleiv H; Berge E; Bruins Slot KM; Wardlaw JM
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009292. PubMed ID: 30365156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Mielke O; Wardlaw J; Liu M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000514. PubMed ID: 15494998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    Ciccone A; Motto C; Abraha I; Cozzolino F; Santilli I
    Cochrane Database Syst Rev; 2014 Mar; (3):CD005208. PubMed ID: 24609741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke.
    Wardlaw JM; Warlow CP; Counsell C
    Lancet; 1997 Aug; 350(9078):607-14. PubMed ID: 9288042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Liu M; Wardlaw J
    Cochrane Database Syst Rev; 2000; (2):CD000514. PubMed ID: 10796381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants for acute ischaemic stroke.
    Wang X; Ouyang M; Yang J; Song L; Yang M; Anderson CS
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD000024. PubMed ID: 34676532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
    ; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
    Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for acute ischemic stroke.
    Cornu C; Amsallem E; Serradj-Jaillard A A
    Am J Cardiovasc Drugs; 2001; 1(4):281-92. PubMed ID: 14728027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.
    Rodrigues FB; Neves JB; Caldeira D; Ferro JM; Ferreira JJ; Costa J
    BMJ; 2016 Apr; 353():i1754. PubMed ID: 27091337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.
    Wardlaw JM; Murray V; Berge E; del Zoppo G; Sandercock P; Lindley RL; Cohen G
    Lancet; 2012 Jun; 379(9834):2364-72. PubMed ID: 22632907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.